|
WO2020073044A1
|
|
Combination therapy for treating cancer
|
|
US2017261508A1
|
|
Methods for monitoring cd4+ t-helper type 1 response in cancer and immune restoration
|
|
WO2016190940A1
|
|
Manufacturing multi-dose injection ready dendritic cell vaccines
|
|
EP3268464A1
|
|
Methods for monitoring cd4+ t-helper type 1 response in cancer and immune restoration
|
|
CN107533065A
|
|
CD4 is monitored in cancer and immune restoration+The method of 1 type t helper cell response
|
|
US2018171294A1
|
|
In vitro artificial lymph node method for sensitization and expansion of t cells for therapy and epitope mapping
|
|
CN107109365A
|
|
The preparation of multiple dose injection dendritic cell vaccine and the therapeutic alliance for blocking HER2 and HER3
|
|
CA2955456A1
|
|
Identification of immunogenic mhc class ii peptides for immune-based therapy
|
|
CA2955445A1
|
|
Manufacturing of multi-dose injection ready dendritic cell vaccines and combination therapy for blocking her2 and her3
|
|
CA2942721A1
|
|
Methods for monitoring cd4+ t-helper type 1 response in cancer and immune restoration
|
